Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
 | NOVO NORDISK | 6 | 40 | +0,12 % | |
| JYSKE BANK | 3 | 3 | -0,56 % | |
| DANSKE BANK | 2 | 10 | -0,52 % | |
| VESTAS WIND SYSTEMS | 2 | 9 | -2,46 % | |
| ZEALAND PHARMA | 2 | 1 | -2,13 % | |
| AP MOELLER-MAERSK | 1 | 23 | -0,05 % | |
| BAVARIAN NORDIC | 1 | 7 | -1,27 % | |
| DSV | 1 | 4 | -0,96 % | |
| AL SYDBANK | 1 | 2 | -1,05 % | |
| ISS | 1 | 1 | -0,56 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 13:42 | JEFFERIES stuft NOVO NORDISK auf 'Hold' | 32 | dpa-AFX-Analyser | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Novo Nordisk auf "Hold" mit einem Kursziel von 270 dänischen Kronen belassen. Das Präparat Etavopivat zur Behandlung von... ► Artikel lesen | |
| 13:38 | NOVO NORDISK A/S: Stabilität als strategischer Faktor | 3 | Maximilian Berger | ||
| 13:30 | Vestas Wind Systems ÜBERRASCHT Anleger: Könnte die Aktie jetzt komplett durchstarten? - Das sollten Sie jetzt wissen | Hebelschein-Spekulant | |||
| 13:30 | Bavarian Nordic A/S: Bavarian Nordic - Transactions in Connection with Share Buy-Back Program | 4 | GlobeNewswire (USA) | ||
| 13:30 | ISS A/S: Transactions in connection with share buyback programme | 3 | GlobeNewswire (USA) | ||
| 13:00 | SolTech Energy Sweden AB: Soltech Energy Solutions takes the next step in its Nordic expansion through installation and commissioning project for DSV in Denmark - order value of SEK 10 million | 39 | GlobeNewswire (Europe) | After recently announcing its entry into Finland, Soltech Energy Solutions is now taking the next step in its Nordic expansion. Through an assignment for the international logistics company DSV, Soltech... ► Artikel lesen | |
| 12:54 | Royal UNIBREW A/S: Share buy-back Program | 2 | GlobeNewswire (USA) | ||
| 12:26 | Novo Nordisk Announces Partnership with OpenAI | 20 | Insider Monkey | ||
| 11:50 | NOVO NORDISK A S - 6-K, Report of foreign issuer | 3 | SEC Filings | ||
| 11:34 | Novo Nordisk A/S: Novo Nordisk: Etavopivat is the first in a new class of drugs to meet both co-primary endpoints in the phase 3 HIBISCUS trial, substantially reducing vaso-occlusive crisis events and improving haemoglobin response in sickle cell disease | 254 | GlobeNewswire (Europe) | Etavopivat showed a 27% reduction in vaso-occlusive crisis events and ~4-month delay to first vaso-occlusive crisis event on top of standard of care1Haemoglobin response was superior with etavopivat:... ► Artikel lesen | |
| 11:24 | AL Sydbank A/S share buyback programme: transactions in week 16 | 3 | GlobeNewswire (USA) | ||
| 10:06 | Danske Bank A/S: Danske Bank share buy-back programme: transactions in week 16 | 3 | GlobeNewswire (USA) | ||
| 10:06 | Tryg A/S: Tryg - Transactions in connection with share buyback programme | 6 | GlobeNewswire (USA) | ||
| 09:06 | Jyske Bank buys back shares worth DKK 58.1m in week 16 | 3 | Investing.com | ||
| 08:58 | Jyske Bank erwirbt in Woche 16 Aktien im Wert von 58,1 Mio. DKK | 2 | Investing.com Deutsch | ||
| 08:36 | Jyske Bank: Share repurchase programme: Transactions of week 16 2026 | 2 | GlobeNewswire (USA) | ||
| 06:23 | Aufgepasst Eli Lilly & Novo: Aussichtsreicher Adipositas-Konkurrent startet stark an der Nasdaq! | 433 | wallstreetONLINE | Ein neuer Herausforderer betritt die größte Wachstumsarena der Pharmaindustrie und bringt mit Ribupatid einen potenziellen Gamechanger im Milliardenmarkt für Abnehmmedikamente mit. Nach starken IPO... ► Artikel lesen | |
| 00:03 | Maersk sets congestion fee of up to $700 on South Europe cargo to Freetown | 4 | PortNews | ||
| So | Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons | 4 | GlobeNewswire (USA) | ||
| So | Zealand Pharma launches long-term incentive programs for Zealand Pharma's Board of Directors, Corporate Management and employees for 2026 | 137 | GlobeNewswire (Europe) | Company announcement - No. 7 / 2026 Zealand Pharma launches long-term incentive programs for Zealand Pharma's Board of Directors, Corporate Management and employees for 2026 Copenhagen, Denmark, April... ► Artikel lesen |
1 2 3 4 5 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.